基于莫林的纳米颗粒用于调节血糖
Ziqi Hua1, Yanfei Li1, Tao Chen1
1SKL of Marine Food Processing & Safety Control, National Engineering Research Center of Seafood, School of Food Science and Technology, Dalian Polytechnic University, Dalian 116034, China.
ACS applied materials & interfaces
|April 19, 2024
概括
这项研究开发了在微凝中封装的新型纳米级莫林颗粒,以改善口服输送. 增强的配方有效调节血糖,并减少糖尿病模型中的炎症.
科学领域:
- 生物材料科学 生物材料科学
- 药理学 药理学是指药理学的学科.
- 自然产品化学 自然产品化学
背景情况:
- 摩林是一种天然化合物,具有治疗潜力,但面临生物可用性挑战.
- 溶解性差和快速清除限制了莫林在血糖调节中的有效性.
- 开发有效的输送系统对于像morin这样的天然化合物至关重要.
研究的目的:
- 创建一种新型的莫林输送系统,以提高其生物可用性和治疗疗效.
- 研究纳米尺寸的莫林颗粒 (MNs) 封装在酸微凝 (M@SA) 中,对血糖调节的疗效.
- 在糖尿病模型中评估M@SA配方的抗炎和器官保护作用.
主要方法:
- 纳米大小的莫林颗粒 (MNs) 的酶合成使用胡卜过氧化酶.
- 通过电动力微滴喷射将MNs封装成藻酸盐微凝 (M@SA).
- 在糖尿病小鼠体内研究评估血糖,脂质概况,氧化应激和器官损伤.
主要成果:
- M@SA微凝证明了长时间的肠保留和优越的疗效超过未经修改的morin.
- 纳米化莫林颗粒 (MNs) 增强了HepG2细胞的葡萄糖吸收.
- 在糖尿病小鼠中,M@SA微凝有效调节了血糖,改善了脂质谱,减少了氧化应激,并减轻了器官损伤.
结论:
- 在酸微凝中封装的酶合成的纳米级莫林颗粒为口服莫林输送提供了一个有前途的策略.
- 这种配方显著提高了血糖调节的治疗效果.
- M@SA方法有可能在口服天然化合物中得到更广泛的应用.
相关概念视频
01:06Oral Hypoglycemic Agents: Glinides
154
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
154
01:19Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
174
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
174
01:23Dipeptidyl Peptidase 4 Inhibitors
182
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
182
01:16Hormones Regulating Blood Glucose
3.3K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
3.3K
01:15Hypoglycemia and Glucagon
257
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
257
01:26Glucose Absorption Into the Small Intestine
31.6K
Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and...
31.6K